MAOLAC is a biotechnology startup focused on preventive nutrition by developing Active Immune Proteins derived from bovine colostrum. These proteins are designed to enrich both human and animal foods, providing targeted immune support and health benefits. The company leverages computational biology to create specifically formulated mixtures for various demographics including infants, athletes, adults, elders, livestock, and pets. These formulations aim to improve gut health, relieve joint pain, and reduce skin infections, among other benefits.

MAOLAC operates in the health and wellness market, targeting both the human and animal sectors. Its business model revolves around the development and sale of bio-functional ingredients that can be incorporated into foods and supplements. The company generates revenue through the sale of these specialized protein mixtures to food manufacturers, supplement companies, and potentially direct-to-consumer channels.

Founded with the vision to harness the biological wonders of breastmilk proteins, MAOLAC aims to improve the wellbeing of all living creatures. By focusing on the unique benefits of colostrum, the company is at the forefront of creating next-generation health solutions.

Keywords: biotech, preventive nutrition, immune proteins, bovine colostrum, gut health, joint pain relief, skin infection reduction, computational biology, bio-functional ingredients, health and wellness.